- Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105
[作者:Yamamoto, N; Nakagawa, K; Nishimura, Y; Tsujino, K; Satouchi, M; Kudo, S; Hida, T; Kawahara, M; Takeda, K; Katakami, N; Sawa, T; Yokota, S; Seto, T; Imamura, F; Saka, H; Iwamoto, Y; Semba, H; Chiba, Y; Uejima, H; Fukuoka, M,期刊:Journal of clinical oncology, 页码:3739-3745 , 文章类型: Article,,卷期:2010年28-23]
- Purpose This phase III trial of concurrent thoracic radiotherapy (TRT) was conducted to compare third-generation chemotherapy with second-generation chemotherapy in patients with unresectable stage III non-small-cell lun...
- Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
[作者:Hendlisz, A; Van den Eynde, M; Peeters, M; Maleux, G; Lambert, B; Vannoote, J; De Keukeleire, K; Verslype, C; Defreyne, L; Van Cutsem, E; Delatte, P; Delaunoit, T; Personeni, N; Paesmans, M; Van Laethem, JL; Flamen, P,期刊:Journal of clinical oncology, 页码:3687-3694 , 文章类型: Article,,卷期:2010年28-23]
- Purpose Liver dissemination is a major cause of mortality among patients with advanced colorectal cancer. Hepatic intra-arterial injection of the beta-emitting isotope yttrium-90 (Y-90) bound to resin microspheres (radio...
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
[作者:Duval, M; Klein, JP; He, WS; Cahn, JY; Cairo, M; Camitta, BM; Kamble, R; Copelan, E; de Lima, M; Gupta, V; Keating, A; Lazarus, HM; Litzow, MR; Marks, DI; Maziarz, RT; Rizzieri, DA; Schiller, G; Schultz, KR; Tallman, MS; Weisdorf, D,期刊:Journal of clinical oncology, 页码:3730-3738 , 文章类型: Article,,卷期:2010年28-23]
- Purpose Patients with acute leukemia refractory to induction or reinduction chemotherapy have poor prognoses if they do not undergo hematopoietic stem-cell transplantation (HSCT). However, HSCT when a patient is not in c...
- Neoadjuvant Treatment of Unresectable Medullary Thyroid Cancer With Sunitinib
[作者:Cleary, JM; Sadow, PM; Randolph, GW; Palmer, EL; Lynch, TP; Nikiforov, YE; Wirth, LJ,期刊:Journal of clinical oncology, 页码:E390-E392 , 文章类型: Editorial Material,,卷期:2010年28-23]
-
- Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
[作者:Moraska, AR; Sood, A; Dakhil, SR; Sloan, JA; Barton, D; Atherton, PJ; Suh, JJ; Griffin, PC; Johnson, DB; Ali, A; Silberstein, PT; Duane, SF; Loprinzi, CL,期刊:Journal of clinical oncology, 页码:3673-3679 , 文章类型: Article,,卷期:2010年28-23]
- Purpose Fatigue is one of the most common symptoms experienced by patients with cancer. This trial was developed to evaluate the efficacy of long-acting methylphenidate for improving cancer-related fatigue and to assess ...
- Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel
[作者:Berruti, A; Fassnacht, M; Baudin, E; Hammer, G; Haak, H; Leboulleux, S; Skogseid, B; Allolio, B; Terzolo, M,期刊:Journal of clinical oncology, 页码:E401-E402 , 文章类型: Letter,,卷期:2010年28-23]
-
- High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
[作者:Morschhauser, F; Kraeber-Bodere, F; Wegener, WA; Harousseau, JL; Petillon, MO; Huglo, D; Trumper, LH; Meller, J; Pfreundschuh, M; Kirsch, CM; Naumann, R; Kropp, J; Horne, H; Teoh, N; Le Gouill, S; Bodet-Milin, C; Chatal, JF; Goldenberg, DM,期刊:Journal of clinical oncology, 页码:3709-3716 , 文章类型: Article,,卷期:2010年28-23]
- Purpose Fractionated radioimmunotherapy targeting CD22 may substantially improve responses and outcome in non-Hodgkin's lymphoma (NHL). Patients and Methods A multicenter trial evaluated two or three weekly infusions of ...
- Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study
[作者:Mauz-Korholz, C; Hasenclever, D; Dorffel, W; Ruschke, K; Pelz, T; Voigt, A; Stiefel, M; Winkler, M; Vilser, C; Dieckmann, K; Karlen, J; Bergstrasser, E; Fossa, A; Mann, G; Hummel, M; Klapper, W; Stein, H; Vordermark, D; Kluge, R; Korholz, D,期刊:Journal of clinical oncology, 页码:3680-3686 , 文章类型: Article,,卷期:2010年28-23]
- Purpose Vincristine, etoposide, prednisone, and doxorubicin (OEPA)-cyclophosphamide, vincristine, prednisone, and dacarbazine (COPDAC) is derived from standard vincristine, procarbazine, prednisone, and doxorubicin (OPPA...
- Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
[作者:Rudloff, U; Jacks, LM; Goldberg, JI; Wynveen, CA; Brogi, E; Patil, S; Van Zee, KJ,期刊:Journal of clinical oncology, 页码:3762-3769 , 文章类型: Article,,卷期:2010年28-23]
- Purpose While the mortality associated with ductal carcinoma in situ (DCIS) is minimal, the risk of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) is relatively high. Radiation therapy (...
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
[作者:Burstein, HJ; Prestrud, AA; Seidenfeld, J; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Malin, J; Mamounas, EP; Rowden, D; Solky, AJ; Sowers, MR; Stearns, V; Winer, EP; Somerfield, MR; Griggs, JJ,期刊:Journal of clinical oncology, 页码:3784-3796 , 文章类型: Article,,卷期:2010年28-23]
- Purpose To develop evidence-based guidelines, based on a systematic review, for endocrine therapy for postmenopausal women with hormone receptor-positive breast cancer. Methods A literature search identified relevant ran...
- Deletion of the PER3 Gene on Chromosome 1p36 in Recurrent ER-Positive Breast Cancer
[作者:Climent, J; Perez-Losada, J; Quigley, DA; Kim, IJ; Delrosario, R; Jen, KY; Bosch, A; Lluch, A; Mao, JH; Balmain, A,期刊:Journal of clinical oncology, 页码:3770-3778 , 文章类型: Article,,卷期:2010年28-23]
- Purpose To investigate the role of the PER3 circadian rhythm gene, located within the commonly deleted region of chromosome 1p36, in human breast cancer development. Patients and Methods The frequency of genetic alterati...
|